Hwabao WP CSI Hong Kong Connect Medical Treatment Thematic ETF

516500

159859

588250

159137

520690

513700

513120

159883

520850

159898

The Fifth International Healthcare Week will take place in Hong Kong from May 11 to 31, featuring the Asia Summit on Global Health and the Hong Kong International Medical and Healthcare Fair. Organized by the HKTDC, the events aim to enhance Hong Kong's role as a medical technology and investment hub, focusing on biopharmaceuticals, AI healthcare, and traditional Chinese medicine. The summit will include discussions on pandemic preparedness and healthcare breakthroughs, with participation from international health officials and industry experts.

Asian Corporate Newswire

ChinaAMC CSI Biotechnology Theme ETF

Tianhong CNI BIOMEDICINE ETF

Penghua SSE STAR Biology and Medicine ETF

Bosera Hang Seng SCHK Innovative Drug Select ETF

Penghua CSI HK Connect Health Care Composite ETF

ChinaAMC SSE STAR Biology and Medicine ETF

Ping An CSI Medicine and Medical Device Innovation ETF

China Southern Hang Seng Biotech ETF(QDII)

GF CSI HK Innovative Drugs Industry ETF(QDII)

Maxwealth CSI All Share Medical Apparatus and Instruments ETF

E Fund Hang Seng SCHK Innovative Drug ETF

ChinaAMC SSE Health Care ETF Initiating Fund

E Fund CSI Hong Kong Connect Medical Treatment Thematic ETF

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

ChinaAMC CSI All Share Health Care Devices ETF

China Merchants CSI Biotechnology Theme ETF

China Merchants CSI All Share Medical Apparatus and Instruments ETF

Minsheng Royal CSI Biotechnology Theme ETF

CAM HSBIOTECH

The Fifth International Healthcare Week set for next month, to highlight Hong Kong's position as medical technology and investment hub

520510

03174

03032

As of April 16, 46 Hong Kong stock thematic funds have been launched this year, doubling the number from the same period last year. Currently, 11 Hong Kong stock thematic funds are being issued, with another 4 set to start soon. In terms of investment direction, technology and healthcare sectors have attracted significant attention, particularly the Hong Kong Connect Information Technology Thematic ETF and multiple medical thematic ETFs currently under issuance

Wallstreetcn

ChinaAMC CSI Hong Kong Connect Medical Treatment Thematic ETF

Huaan Hang Seng SCHK Technology ETF

Dacheng Hang Seng Technology ETF(QDII)

Bosera Hang Seng Health Care ETF(QDII)

Hwabao WP CSI HK Connect Information Technology Composite ETF

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

Tianhong Hang Seng TECH ETF(QDII)

Huatai-PB CSOP Hang Seng Technology ETF(QDII)

CSOP HEALTHCARE

CSOP HS TECH

ChinaAMC Hang Seng Technology ETF(QDII)

HSTECH ETF

Hang Seng TECH ETF I

Tianhong CSI Robot ETF

Focusing on Technology and Healthcare Sectors, 46 Hong Kong Stock Thematic Funds Launched This Year

STECH

513770

513040

520630

520910

513200

03088

On April 15th, the Hong Kong stock market continued to rebound, with the pharmaceutical sector leading the gains, and technology and internet leaders also performing strongly. The CSI Hong Kong Connect Medical and Health Integration Index rose by 3.6%, the internet index increased by 1.4%, the new economy index climbed by 1.3%, and the technology index went up by 1.2%. The trading volume of the Hong Kong Connect Internet ETF reached HKD 700 million, indicating capital inflow. Risk warning: Investment should be cautious

腾讯新闻 - 财经

Hang Seng TECH Index

Hwabao CSI HK Equities Internet ETF

E Fund CSI HK Connect Internet ETF

GF Fund CSI Hong Kong Connect Internet ETF

ChinaAMC CSI Hong Kong Connect Internet ETF

E Fund CSI HK Equities Medical and Health Integration ETF

CAM HS TECH

Hong Kong stocks' new economy rebounded across the board, with the pharmaceutical sector leading the gains

159262

159152

159015

520670

159010

On April 13th, Bosera Hang Seng HK Connect Tech ETF, Guolian Hang Seng HK Connect Tech ETF, and Yinhua CSI Hong Kong Connect Medical Treatment Thematic ETF officially began issuance, marking the acceleration of the issuance boom for Hong Kong stock thematic funds. Since the beginning of this year, 46 new Hong Kong stock thematic funds have been established, doubling in number. ETFs have become the core tool for institutional allocation, covering sectors such as healthcare, automotive, and information technology. At the same time, public fund institutions are exploring excess returns through enhanced index funds and selective funds

GF Fund Hang Seng SCHK Technology ETF

Ping An Hang Seng SCHK Technology ETF

Guolian Hang Seng SCHK Technology ETF

Harvest Hang Seng SCHK Technology ETF

Bosera Hang Seng HK Connect Tech ETF

The surge in the issuance of Hong Kong stock thematic funds: 46 new products rush to the market, expanding the ETF segmented track

512170

159873

159828

36Kr learned that CITIC Securities pointed out that the turning point for the medical device sector is approaching, and there are opportunities for performance valuation recovery for individual stocks in 2026. Focus on companies that are expected to accelerate growth in 2026 compared to 2025, which may achieve a double boost in performance valuation in the future. In 2026, the A-share medical device sector is recommended to focus on investment opportunities related to performance recovery and overseas expansion, while in the Hong Kong stock market, attention should be paid to the sector effects brought by the listing of several quality medical device companies, as well as the gradual profit release and undervalued layout opportunities of several leading companies in the medical device subsector

36Kr

Hwabao WP CSI Medical Service ETF

Tianhong CSI All Share Health Care Equipment and Services ETF

Guotai CSI Medical Service ETF

CITIC Construction Investment: The turning point for the medical device sector is approaching

159929

The Penghua CSI HK Connect Health Care Composite ETF rose by 0.33%, with the latest price reported at 0.6 yuan. The pharmaceutical sector is active, with the launch of a major national science and technology project focusing on the research and development of drugs for Alzheimer's disease. Guolian Minsheng Securities pointed out that the pharmaceutical sector has entered a bottoming and recovery phase, lacking major catalytic clues in the short term, but expectations for overseas sales are high. The CSI HK Equities Medical and Health Integration Index rose by 0.52%, with the top ten weighted stocks accounting for a total of 65.08%

China Universal 800 Health Care ETF

The Hong Kong Stock Connect Medical ETF Penghua is on the rise, with continuous catalysts in the innovative drug sector

159992

09820

ALPHAMAB-B (9966.HK) has seen a continuous decline after the market closed on January 20, with the overall Hong Kong biotechnology sector lacking excitement. The company has not announced any significant clinical progress or financing recently, and although trading volume slightly increased throughout the day, there was no significant action from major players, as investors' focus has shifted back to sector rotation. There are rumors in the news that the adjustment window for the medical insurance catalog is approaching, and market funds are leaning towards innovative drugs and emerging sectors, while ALPHAMAB has not shown significant movement following the hot trends. The intraday fluctuations have been mild, with no significant gathering of major players, and the buying pressure remains to be validated. On the technical side, the MACD continues to trend downward, and the 5-day moving average is providing short-term resistance, raising doubts about the sustainability of any rebound. Moving forward, attention should be paid to the substantive progress of medical insurance negotiations and the future structural rotation of the sector. If the biotechnology sector experiences another overall pullback or if the company faces unexpected negative news, short-term pressure may significantly increase. The operational suggestion is to continue observing from the right side, closely track marginal policy changes and sector movements, and wait for signals of major capital action to emerge

Technical Forecast

Yinhua CSI Innovative Drugs Industry ETF

GX CN BIOTECH-U

Yinhua CSI HK Equities Medical and Health Integration ETF

GX CN BIOTECH

CAM HSBIOTECH-U

Ping An CSI HK Equities Medical and Health Integration ETF

Tianhong Hang Seng Shanghai-Shenzhen-Hong Kong Innovative Drugs Selected 50 ETF

ALPHAMAB-B

Morning Trend | ALPHAMAB is testing the bottom with reduced volume, will the main opportunities in the pharmaceutical sector rotate?

Hwabao WP CSI Hong Kong Connect Medical Treatment Thematic ETF(159137.SZ)